Results 291 to 300 of about 305,628 (395)

Catheter directed interventions for acute deep vein thrombosis.

Cardiovascular Diagnosis and Therapy, 2016
M. Kohi, R. Kohlbrenner, K. Kolli, E. Lehrman, Andrew G. Taylor, N. Fidelman   +5 more
semanticscholar   +1 more source

Venous thromboembolism risk following surgery during the COVID‐19 pandemic

Anaesthesia, EarlyView.
Summary Introduction SARS‐CoV‐2 infection is associated with an increased risk of venous thromboembolism. Data are lacking on how this risk altered during the COVID‐19 pandemic and following vaccination. We aimed to evaluate the 90‐day risk of postoperative venous thromboembolism during the pandemic. Methods We performed a retrospective cohort study of
Andrew Jackson, David J. Humes, Amir Mehrkar, Sebastian C. J. Bacon, Simon Davy, Ben Goldacre, Joe West, Colin J. Crooks   +7 more
wiley   +1 more source

Association of thrombocytopenia with deep vein thrombosis in patients with acute exacerbations of chronic obstructive pulmonary disease: A retrospective study. [PDF]

Exp Ther Med
Guo Y, Wang L, Wang Z, Wang Y, Lin Q, Zhang X, Wu L, Wan B.   +7 more
europepmc   +1 more source

The Orthotic Effect of Functional Electrical Stimulation on Reactive Stepping for People With Incomplete Spinal Cord Injury

Artificial Organs, EarlyView.
This study evaluated the orthotic effect of functional electrical stimulation (FES) on reactive stepping in 16 participants with chronic, motor incomplete spinal cord injury (iSCI). Participants completed 10–20 trials of the Lean‐and‐Release test, with FES applied in half at random.
Matthew G. Heffernan, Jonguk Lee, Katherine Chan, Elizabeth L. Inness, Kei Masani, Kristin E. Musselman   +5 more
wiley   +1 more source

Biliary Glutathione as a Potential Marker for Viability Assessment of Cholangiocytes During Normothermic Machine Perfusion of Livers

Artificial Organs, EarlyView.
This study identifies biliary glutathione concentration during normothermic machine perfusion as a potential biomarker for biliary viability. Increasing GSH levels correlate with fewer biliary complications post‐transplant, supporting its role in assessing graft quality and improving decision‐making in liver transplantation.
Christina Bogensperger, Hannah Esser, Florian Ponholzer, Benno Cardini, Julia Hofmann, Franka Messner, Rupert Oberhuber, Thomas Resch, Dietmar Öfner, Stefan Schneeberger, Annemarie Weissenbacher   +10 more
wiley   +1 more source

Effect of lunar phases on international normalized ratio in patients with deep vein thrombosis using warfarin. [PDF]

J Educ Health Promot
Orhan A, Sengul Bag F.
europepmc   +1 more source

The Impact of Obesity on Durable Left Ventricular Assist Device Implantation: A Systematic Review and Meta‐Analysis

Artificial Organs, EarlyView.
14 100 LVAD patients across 21 studies were analyzed. Findings indicated that obese LVAD recipients had lower short‐term mortality and higher risk of infection, thrombosis and right heart failure. There was no difference in long‐term survival between obese and non‐obese patients.
Hugh Jacobs, Olivia Frost, Arian Arjomandi Rad, Wing Kiu Chou, Sadeq Al‐Saegh, Alina Zubarevich, Alexander Weymann, Arjang Ruhparwar, Lukman Amanov, Peyman Sardari Nia, Antonios Kourliouros, Thanos Athanasiou   +11 more
wiley   +1 more source

Immunomodulation and Thrombolytic Approaches in the Management of Deep Vein Thrombosis and Pulmonary Embolism. [PDF]

Cardiol Cardiovasc Med
Pathak A, Roberts L, Agrawal DK.
europepmc   +1 more source

Further Research is Necessary to Demonstrate Potential Advantages of Ultrasound Assisted Catheter Directed Thrombolysis in the Management of Proximal Deep Vein Thrombosis [PDF]

Mohammed Ashrafi, Stavros A. Antoniou, George Α. Antoniou   +2 more
openalex   +1 more source

Hemocompatibility and Long‐Term Outcomes in HeartWare Versus HeartMate II Versus HeartMate 3: Multicenter Real‐World Cohort

Artificial Organs, EarlyView.
Multicenter real‐world cohort (n = 327) comparing LVADs: HeartMate 3 (HM3), HeartMate II (HMII), and HeartWare (HVAD). HM3 showed superior long‐term survival versus legacy devices, driven by fewer hemocompatibility‐related adverse events, especially pump thrombosis and ischemic stroke, while major bleeding was similar across devices.
Hamza H. H. Ben Nasir, Ahmed F. A. Mohammed, Omar Allham, Alish Kolashov, Yusuf Shieba, Lachmandath Tewarie, Bernd Panholzer, Ajay Moza, Assad Haneya, Rashad Zayat   +9 more
wiley   +1 more source